Concepedia

E.S. Ellis

EE

7

Publications

398

Citations

7

H-Index

1994

Active since

Affiliations

New Frontier(Current)

Molecular Discovery (United Kingdom)

E.S. Ellis is an author at New Frontier specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1994–2002

7

Publications

7

5‐HT<sub>2B</sub> receptors play a key role in mediating the excitatory effects of 5‐HT in human colon <i>in vitro</i>

R. A. Borman, Nicholas S. Tilford, Dan W. Harmer et al. · British Journal of Pharmacology · 2002 · 115 citations · Full text

, , +18

Mediation by 5‐hydroxytryptamine<sub>2B</sub>receptors of endothelium‐dependent relaxation in rat jugular vein

E.S. Ellis, Clare Byrne, Olive E. Murphy et al. · British Journal of Pharmacology · 1995 · 96 citations · Full text

The effects of SB 204070, a highly potent and selective 5‐HT<sub>4</sub>receptor antagonist, on guinea‐pig distal colon

Kay A. Wardle, E.S. Ellis, Gordon S. Baxter et al. · British Journal of Pharmacology · 1994 · 72 citations · Full text

N-[(1-Butyl-4-piperidinyl)methyl]-3,4- dihydro-2H-[1,3]oxazino[3,2-a]indole- 10-carboxamide hydrochloride: the first potent and selective 5-HT4 receptor antagonist amide with oral activity.

Laramie M. Gaster, Graham F. Joiner, F. D. KING et al. · Journal of Medicinal Chemistry · 1995 · 43 citations · Full text

, , +19

Selective and functional 5‐hydroxytryptamine<sub>4</sub> receptor antagonism by SB 207266

Kay A. Wardle, Sharon Bingham, E.S. Ellis et al. · British Journal of Pharmacology · 1996 · 40 citations · Full text

Rows per page

1–5 of 7